# Eli Lilly to build $3.5B injectable medicine plant in Fogelsville, Pennsylvania

Eli Lilly announced a $3.5 billion investment to build a new injectable medicine and device manufacturing facility in Fogelsville, Lehigh Valley, Pennsylvania, focused on next-generation weight-loss therapies including retatrutide. The facility is expected to create 850 permanent jobs and begin operations in 2031.

- Type: New facility
- Announced: 2026-01-30
- Where: Fogelsville, Lehigh Valley, Pennsylvania, United States
- Value: $3.50B
- Jobs: 850
- Starts operating: 2031
- Status: announced
- Products: injectable medicines, medical devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Eli Lilly](https://endata.com/companies/32564.md)

## Sources

- [stocktitan.net](https://www.stocktitan.net/news/LLY/lilly-selects-pennsylvania-as-home-for-its-newest-injectable-hduh3emtkm8t.html), 2026-01-30: "Lilly selects Pennsylvania as home for its newest injectable medicine and device manufacturing facility."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.